About Neuralink
                            Neuralink develops a brain machine interface that provides solutions for those with paralysis.                        
                                                    
                                    Headquarters
                                    Neuralink, Fremont
                                
                                                                                                
                                    Founded
                                    2016-01-01
                                
                                                                
                                                                
                                    Industry
                                    Biotechnology, Medical, Neuroscience, Robotics
                                
                                                                                                
                                    Last Funding Type
                                    Secondary Market
                                
                                                                                                    
                                        Valuation
                                        4
                                    
                                                                                                
                                                                        Total Funding
                                    $686.24 million dollars
                                
                                                                                                
                                    IPO Status
                                    Private
                                
                                                            Financial
                                Neuralink is advancing brain-machine interfaces through various technologies. They are developing static and dynamic input multiplexing for high-density neural signal recording, which enhances the ability to process neural data. Their research includes wireless pairing systems for neural implants, allowing seamless communication between implanted and external devices. Additionally, they are working on neural signal compression techniques to efficiently manage data from brain-machine interfaces. These efforts highlight Neuralink's focus on improving neural data acquisition, processing, and communication for brain-machine interfaces.
Neuralink has encountered issues with its first human brain implant, including thread retraction and data loss. Despite these setbacks, the FDA has approved the implantation of a second patient. The company is actively seeking participants for further trials to evaluate and improve the device.
                            
                            Neuralink has encountered issues with its first human brain implant, including thread retraction and data loss. Despite these setbacks, the FDA has approved the implantation of a second patient. The company is actively seeking participants for further trials to evaluate and improve the device.
                                    Funding Rounds
                                    7
                                
                                                                                                
                                    Number of Lead Investors
                                    2
                                
                                                                                                
                                                                        Total Funding Amount 
                                    $686.24 million dollars
                                
                                                                                                
                                    Number of Investors
                                    24